alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.1

                                   SECTION 302
                  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Avi Friedman, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of VB Trade, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, the results of operations and cash flows of the small
business issuer as of, and for, the periods presented in this report;

4. The small business issuer's other certifying officer(s) and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and
have:

     (a) designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the small business issuer,
including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being
prepared;
     (b) evaluated the effectiveness of the small business issuer's disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and
     (c) disclosed in this report any change in the small business issuer's
internal control over financial reporting that occurred during the small
business issuer's most recent fiscal quarter that has materially affected, or is
reasonably likely to materially affect, the small business issuer's internal
control over financial reporting; and

5. The small business issuer's other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the small business issuer's auditors and the audit committee of
the small business issuer's board of directors (or persons performing the
equivalent functions):

     (a) all significant deficiencies in the design or operation of internal
control over financial reporting which are reasonably likely to adversely affect
the small business issuer's ability to record, process, summarize and report
financial information; and
     (b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer's internal
control over financial reporting.


Date: May 3, 2007      By /s/ Avi Friedman
                          ------------------------------------------
                          Avi Friedman,
                          President, Principal Executive Officer
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL OF FLORIDA SECOND DISTRICT

DONAVAN LEIGH PATTERSON, ) DOC #R92413, ) ) Appellant, ) ) v. ) Case No. 2D17-5070 ) STATE OF FLORIDA, ) ) Appellee. ) ________________________________ ) Opinion filed May 10, 2019. Appeal from the Circuit Court for Pinellas County; Frank Quesada, Judge. Howard L. Dimmig, II, Public Defender, and Timothy J. Ferreri, Assistant Public Defender, Bartow, for Appellant. Ashley Moody, Attorney General, Tallahassee, for Appellee.

PER CURIAM.

Affirmed.

NORTHCUTT, SILBERMAN, and ROTHSTEIN-YOUAKIM, JJ., Concur.
#### Elija T. SMITH, Appellant, v. The STATE of Texas, Appellee.

No. 708-94.

Court of Criminal Appeals of Texas, En Banc.

Oct. 26, 1994.

Robert A. Morrow, (Court-appointed on appeal), Houston, for appellant.

John B. Holmes, Jr., Dist. Atty., and Alan Curry and Larry McDougal, Asst. Dist. At-tys., Houston, Robert Huttash, State’s Atty., Austin, for the State.

Appellant’s petition for discretionary review refused.

BAIRD, Judge,

concurring to the refusal of appellant’s petition for discretionary review.

Appellant was convicted of possession of a controlled substance and sentenced to thirty years confinement. The Court of Appeals affirmed. *Smith v. State,*874 S.W.2d 720 (Tex.App.—Houston [1st Dist.] 1994). In his petition for discretionary review appellant contends the tests conducted by the State to determine or identify a controlled substance, and the results from those tests, were insufficient to support the jury’s verdict.1

A majority of the Court has chosen to refuse appellant’s petition. Although I have serious questions concerning the correctness of the Court of Appeal’s opinion, I do not believe the instant record is itself sufficient to address the issues raised in appellant’s petition. Resolution of these issues will require the Court to take judicial notice of a body of scientific evidence that is not before the Court, a practice I believe should be saved for only the most extraordinary situations. *Emerson v. State,*880 S.W.2d 759, 772 (Tex.Cr.App.1994) (Baird, J., dissenting). Therefore, I join the majority in refusing this petition but emphasize our statements in *Sheffield v. State,*650 S.W.2d 813, 814 (Tex.Cr.App.1983):

> To prevent any misunderstanding, we take this opportunity to emphasize that the summary refusal of a petition for discretionary review by this Court is of no prece-dential value. This is true where the petition is refused without opinion, as is the usual practice, as well as where the petition is refused with a brief opinion disavowing the reasoning employed by the Court of Appeals, as in the instant case. The Bench and Bar of the State should not assume that the summary refusal of a petition for discretionary review lends any additional authority to the opinion of the Court of Appeals.

*Id. See also, Hill v. State,*690 S.W.2d 900, 901 (Tex.Cr.App.1985); *May v. State,*660 S.W.2d 888, 890 n. 1 (Tex.App.1983); *O’Brien v. State,*658 S.W.2d 267 (Tex.App.1983); *and, Campbell v. State,*647 S.W.2d 660 (Tex.Cr.App.1983).

*949With these comments, I concur in the majority’s refusal of appellant’s petition for discretionary review.

1

. Appellant’s ground for review states:

> Is the evidence sufficient to sustain a conviction for possession of a controlled substance when the State does not have a valid scientific test identifying the controlled substance and therefore relies on a field test conducted by a non-expert.
Exhibit 10(h)

 

SUMMARY DESCRIPTION OF TRUSTEES’ COMPENSATION

 

The compensation paid to each individual Trustee and the Corporate Trustee is set forth in the Amendment to the Agreement of Trust dated as of October 25, 1982 (the “Amendment”).  The Amendment is filed as Exhibit 3(a) to the Form 10-K.

 

Pursuant to the Amendment, each individual Trustee receives at least $20,000 in annual compensation for services as Trustee.  Each year, annual Trustee compensation is adjusted up or down (but not below $20,000) in accordance with changes from the November 1981 level of 295.5 (the “1981 Escalation Level”) in the All Commodities Producer Price Index (with 1967 = 100 as a base).  The All Commodities Producer Price Index is published by the U.S. Department of Labor.  The adjustment is made at the end of each fiscal year and is calculated on the basis of the proportion between (a) the level of such index for the November preceding the end of such fiscal year, and (b) the 1981 Escalation Level.  Each of the individual Trustees received $40,715 in cash compensation for services to the Trust during the fiscal year ended January 31, 2014.

 

Also pursuant to the Amendment, Deutsche Bank Trust Company Americas, as the Corporate Trustee, receives annual compensation in an amount equal to the greater of (i) $20,000, or such other amount determined in accordance with the adjustments described in the preceding paragraph, or (ii) one quarter of one percent (1/4 of 1%) of the Trust Moneys, exclusive of proceeds of sale of any part of the Trust Estate (as such terms are defined in the Agreement of Trust), received by the Trustees and distributed to Trust Unitholders.  The Corporate Trustee earned $50,513 pursuant to this provision for the fiscal year ended January 31, 2014.

 

Additionally, each year the Corporate Trustee receives $62,500 (or more, if unanimously approved by the individual Trustees) to cover clerical and administrative services to Mesabi Trust other than services customarily performed as a registrar or transfer agent.  In fiscal 2014, the Trust paid the Corporate Trustee $62,500 to cover clerical and administrative services to Mesabi Trust and $8,081 for services as the registrar and transfer agent of the Trust.  The Corporate Trustee earned $121,094 in total compensation for the fiscal year ended January 31, 2014.
EXHIBIT 10.52


 


First Amendment to Employment Agreement
of


Matthew Schwartz dated February 23, 2012


(“Employment Agreement”)


 


The undersigned parties agree as follows effective March 1,
2014:


 


		1.	All definitions shall be as set forth in the Employment Agreement



		2.	The Employment Agreement is hereby extended through August 31, 2014 (the “Extended Term”).



		3.	From and after March 1, the Executive’s monthly base salary shall be $12,500 per month.



		4.	On or before March 15, 2014, the Company shall pay the Executive $10,000 for his role as Secretary of the Company to date.
This payment shall not be subject to wage withholding as it is being paid to the executive for his role as Secretary.



		5.	On March 15, 2014, the Company shall grant the Executive a warrant for 300,000 shares as Secretary of the Company to date and
through the end of the Extended Term. The warrant shares shall vest at the rate of 50,000 shares each month through the end of
the Extended Term. The warrant shall have a term of five (5) years with an exercise price of $0.31 per share. All other terms and
provisions of the warrant shall be identical to warrants issued to directors of the Company in 2013. Prior to the termination of
the Extended Term, the Company shall register the warrant and warrant shares.



		6.	Upon termination of the Extended Term:



		a.	The warrant and all prior warrants and options granted to the Executive by the Company shall be fully vested and exercisable
according with their terms for the original exercise period, notwithstanding any other agreement or the provisions of any plan
under which any of the options were granted.



		b.	The company shall pay the Executive’s COBRA costs for a period of 12 months, or upon the Executive’s election,
pay the Executive the same amount in cash each month.



 


Approved and accepted by:


 


	GRANDPARENTS.COM, INC	 	EXECUTIVE
	 	 	 
	By:	 	By:
	 	 	 
	/s/ Steve Leber	 	/s/ Matthew Schwartz
	Steve Leber, Co-CEO	 	Matthew Schwartz
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             DEC-26-1998
<PERIOD-END>                               DEC-31-1999
<CASH>                                          37,539
<SECURITIES>                                         0
<RECEIVABLES>                                  577,669
<ALLOWANCES>                                    16,956
<INVENTORY>                                          0
<CURRENT-ASSETS>                               708,390
<PP&E>                                         224,809
<DEPRECIATION>                                  88,833
<TOTAL-ASSETS>                               2,438,901
<CURRENT-LIABILITIES>                          657,902
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           653
<OTHER-SE>                                   1,158,607
<TOTAL-LIABILITY-AND-EQUITY>                 2,438,901
<SALES>                                              0
<TOTAL-REVENUES>                             3,167,971
<CGS>                                                0
<TOTAL-COSTS>                                2,129,181
<OTHER-EXPENSES>                                71,750
<LOSS-PROVISION>                                 6,685
<INTEREST-EXPENSE>                              36,304
<INCOME-PRETAX>                                123,882
<INCOME-TAX>                                    53,049
<INCOME-CONTINUING>                             70,833
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    70,833
<EPS-BASIC>                                       1.29
<EPS-DILUTED>                                     1.27


</TABLE>
[Federal Register Volume 73, Number 148 (Thursday, July 31, 2008)]
[Notices]
[Page 44791]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-17600]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Sunshine Act Meeting

    Notice is hereby given, pursuant to the provisions of the 
Government in the Sunshine Act, Public Law 94-409, that the Securities 
and Exchange Commission will hold a Roundtable on International 
Financial Reporting Standards on Monday, August 4, 2008 beginning at 1 
p.m.
    The Roundtable will take place in the Auditorium of the 
Commission's headquarters at 100 F Street, NE., Washington DC. The 
Roundtable will be open to the public with seating on a first-come, 
first-served basis. Doors will open at 12:30 p.m. Visitors will be 
subject to security checks.
    The roundtable will consist of an open discussion on International 
Financial Reporting Standards (IFRS) and an update on IFRS 
developments, including the experience with use of IFRS during the 
recent period of market turmoil. The roundtable will be organized as 
two panels, each consisting of investors, issuers, auditors and other 
parties with experience in IFRS reporting.
    For further information, please contact the Office of the Secretary 
at (202) 551-5400.

    Dated: July 28, 2008.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. E8-17600 Filed 7-30-08; 8:45 am]
BILLING CODE 8010-01-P
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
The  schedule  contains  summary  financial   information   extracted  from  the
consolidated  balance  sheets  and  consolidated  statements  of  income  and is
qualified in its entirety by reference to such financial statements.
</LEGEND>

       
<S>                                         <C>
<PERIOD-TYPE>                                12-MOS     
<FISCAL-YEAR-END>                            DEC-31-1998  
<PERIOD-END>                                 DEC-31-1998 
<CASH>                                         2,723,454
<SECURITIES>                                           0
<RECEIVABLES>                                  1,340,631 
<ALLOWANCES>                                           0
<INVENTORY>                                      534,643
<CURRENT-ASSETS>                                       0 
<PP&E>                                        43,154,438 
<DEPRECIATION>                                         0
<TOTAL-ASSETS>                                47,803,687 
<CURRENT-LIABILITIES>                                  0
<BONDS>                                                0
<PREFERRED-MANDATORY>                                  0
<PREFERRED>                                            0
<COMMON>                                               0
<OTHER-SE>                                    32,647,177 
<TOTAL-LIABILITY-AND-EQUITY>                  47,803,687 
<SALES>                                          450,186
<TOTAL-REVENUES>                              18,490,540
<CGS>                                                  0
<TOTAL-COSTS>                                 16,744,980
<OTHER-EXPENSES>                                 629,344
<LOSS-PROVISION>                               1,250,000
<INTEREST-EXPENSE>                             1,085,904
<INCOME-PRETAX>                                1,745,560
<INCOME-TAX>                                           0
<INCOME-CONTINUING>                            1,745,560 
<DISCONTINUED>                                         0
<EXTRAORDINARY>                                        0
<CHANGES>                                              0
<NET-INCOME>                                   1,745,560
<EPS-PRIMARY>                                       3.40
<EPS-DILUTED>                                       3.40
        


</TABLE>
[Federal Register Volume 73, Number 148 (Thursday, July 31, 2008)]
[Notices]
[Page 44757]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-17517]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Heart, Lung, and Blood Advisory Council.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Advisory 
Council.
    Date: September 9, 2008.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda MD 20892, (Telephone Conference 
Call).
    Contact Person: Stephen Mockrin, PhD, Director, Division of 
Extramural Research Activities, National Heart, Lung, and Blood 
Institute, National Institutes of Health, 6701 Rockledge Drive, Room 
7100, Bethesda, MD 20892, (301) 435-0260, <a href="/cdn-cgi/l/email-protection#d7bab8b4bca5beb9a497b9bfbbb5bef9b9bebff9b0b8a1"><span class="__cf_email__" data-cfemail="2b46444840594245586b454347494205454243054c445d">[email protected]</span></a>.
    Information is also available on the Institutes/Centers home 
page: http://www.nhlbi.nih.gov/meetings/index.htm, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: July 24, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-17517 Filed 7-30-08; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<page>
			            EXHIBIT 32.01



CERTIFICATION OF PRESIDENT PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Annual Report of Morgan Stanley Charter
Aspect L.P. (the ?Partnership?) on Form 10-K for the period ended
December 31, 2008, as filed with the Securities and Exchange
Commission on the date hereof (the ?Report?), I, Walter Davis,
President of Demeter Management Corporation, the general partner
of the Partnership, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to the best of my knowledge:
(1)	The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents,
in all material respects, the financial condition and
results of operations of the Partnership.





By:	  /s/	Walter Davis

Name:		Walter Davis
Title:	        President

Date:		March 31, 2009
Electronically FiledIntermediate Court of Appeals3008228-JUN-201210:40 AM
EXHIBIT 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the amended Quarterly Report of Lucky Strike Explorations
Inc. (the "Company") on Form 10-QSB/A for the period ending March 31, 2007 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Michael Noble, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the
Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS WHEREOF, the undersigned has executed this certification as of the
8th day of June, 2007.


/s/ Michael Noble
----------------------------
Chief Executive Officer
EXHIBIT 32.2





CERTIFICATION OF VICE PRESIDENT OF CORPORATE FINANCE


PURSUANT TO 18 U.S.C. SECTION 1350


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002








The undersigned, the Chief Financial Officer of Tongji Healthcare Group, Inc. (the "Company"), does hereby certify under the standards set forth and solely for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.





Dated: August 17, 2010



/s/ Weidong HuangWeidong Huang

Chief Financial Officer